PolarCool AB (publ.) has secured a breakthrough 3-year league-wide agreement with the Czech professional Ice Hockey League - Extraliga, worth 2,5 MSEK, starting from the 2025/2026 season.

Under the agreement, PolarCap® will be implemented across the league, as a standardized part of concussion management in the league. This marks a significant progress for PolarCool’s presence in European ice hockey and represents an important step toward achieving positive cash flow for the company.

The league-wide adoption follows the successful introduction of PolarCap® during the 2025 Czech playoff semi-finals and finals—an initiative that generated widespread interest from both the league and participating teams. This momentum has now led to a full-league rollout, marking a major advancement in player safety and welfare across the Extraliga.

Tipsprt Extraleague CEO, Martin Loukota, comments;

-Player safety is our top priority. By introducing PolarCap® across the league, we are taking a major step forward in our medical protocols. The system’s clinically proven benefits, especially in reducing long-term absence after head injuries, made this an easy decision. A league-wide agreement ensures that every player has access to immediate, effective treatment.

PolarCool's CEO, Erik Andersson, comments;

-We are proud that Extraliga is prioritizing player safety by adopting our technology across the league . This decision reflects both the strong clinical support and growing trust in PolarCap®. Transitioning from individual team agreements to full league-wide partnerships has been a key strategic goal for PolarCool, making this agreement a significant breakthrough in expanding our presence in the European ice hockey market. We look forward to building a strong and lasting partnership.

This information is information that PolarCool (publ.) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out herein, on May 16^th, 2025.

For more information

Erik Andersson –  CEO PolarCool AB (publ.)               
+46 - 738 60 57 00                                         
E-mail: erik.andersson@polarcool.se

About PolarCool AB (publ.)

PolarCool AB (publ.) is a Swedish medical technology company focused on developing and marketing products in the sports medicine field. Its primary product, PolarCap®, is designed to reduce the impact of concussion through targeted brain cooling. PolarCool works with professional teams across Europe in rugby, football, and ice hockey and it shares are listed on Spotlight Stock Market